Hatsuyo Kano

Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days

Taku Tsunekawa, Toshio Hayashi, Hatsuyo Kano et al. · Circulation · 2001 · 255 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Plasma Adiponectin Plays an Important Role in Improving Insulin Resistance With Glimepiride in Elderly Type 2 Diabetic Subjects

Taku Tsunekawa, Toshio Hayashi, Yusuke Suzuki et al. · Diabetes Care · 2003 · 109 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen

Toshio Hayashi, Teiji Esaki, Emiko Muto et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 100 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects — the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action

Daigo Sumi, Toshio Hayashi, Navin Kumar Thakur et al. · Atherosclerosis · 2001 · 98 citations

Medicine, Cardiology, Pharmacology +15

A HMG-CoA Reductase Inhibitor Improved Regression of Atherosclerosis in the Rabbit Aorta without Affecting Serum Lipid Levels: Possible Relevance of Up-Regulation of Endothelial NO Synthase mRNA

Hatsuyo Kano, Toshio Hayashi, Daigo Sumi et al. · Biochemical and Biophysical Research Communications · 1999 · 70 citations

Veterinary Medicine, Biochemistry, Inflammation +14